GPX4 and cancer: Since antigens released upon cancer cell death may potentiate the immune checkpoint blockade (the rationale behind the combination with chemotherapy in the clinic setting43,44), and ferroptosis is an effective form of cell death in apoptosis-resistant cancers5,6, intratumoral injection of GPx4 inhibitors might offer a novel strategy to enhance cancer immunotherapy.